GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Other Operating Expense

Realcan Pharmaceutical Group Co (SZSE:002589) Other Operating Expense : ¥275 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Other Operating Expense?

Realcan Pharmaceutical Group Co's Other Operating Expense for the three months ended in Mar. 2024 was ¥7 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥275 Mil.

Realcan Pharmaceutical Group Co's quarterly Other Operating Expense increased from Sep. 2023 (¥-114 Mil) to Dec. 2023 (¥239 Mil) but then declined from Dec. 2023 (¥239 Mil) to Mar. 2024 (¥7 Mil).

Realcan Pharmaceutical Group Co's annual Other Operating Expense declined from Dec. 2021 (¥556 Mil) to Dec. 2022 (¥430 Mil) and declined from Dec. 2022 (¥430 Mil) to Dec. 2023 (¥275 Mil).


Realcan Pharmaceutical Group Co Other Operating Expense Historical Data

The historical data trend for Realcan Pharmaceutical Group Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Realcan Pharmaceutical Group Co Other Operating Expense Chart

Realcan Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 904.92 667.20 555.55 430.45 274.56

Realcan Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.37 142.52 -114.14 238.81 7.31

Realcan Pharmaceutical Group Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥275 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Realcan Pharmaceutical Group Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Traded in Other Exchanges
N/A
Address
No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines